Skip to main content

How Pharma Leaders Talk About Ethics in a Highly Criticized Industry

Member Terri Shieh-Newton, PhD spoke to PharmaVoice about ethical issues in the biopharma industry, particularly as artificial intelligence presents new challenges around safeguarding data and privacy.

Terri commented, “Some AI developers try to balance the attention to ethics with efficiency by incorporating a rules-based approach for what is ethical and what is not as part of their algorithm… One challenge is to define the rules of ethics for the program and then make the determination of how much weight should be given to the ethical rules as part of the machine learning model that also focuses on technical accuracy.”